Ascend Gene & Cell Therapies raises $65.9M from Petrichor Healthcare and Abingworth
05 May 2023
05 May 2023
Total investments received (USD): 65.9M
Round value (USD): 65.9M
Company: Ascend Gene & Cell Therapies
Related deals
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds
Investments
01 September 2025
Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA
Investments
02 August 2025
Juvenescence raised $76m in a first close of its Series B1 round led by M42.
Investments
10 May 2025
Belgium
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal